Searched for
PINE LABS REVENUE Q2FY26
Rupee to average around 96/USD in FY27; risks from oil, dollar persist: Motilal OswalThe Indian rupee is projected to average around 96 against the US dollar in FY27. However, this outlook faces potential challenges includin...- Zepto IPO: Aadit Palicha, Kaivalya Vohra to hold stake; Nexus Ventures biggest seller in OFSQuick commerce firm Zepto's promoters will not dilute equity in its upcoming IPO, which aims to raise Rs 8,010 crore via fresh issue and an...
- Infosys dividend alert! Last date to buy IT giant's shares to secure Rs 25/sh payoutInfosys has set June 10 as the record date to determine shareholder eligibility for its final dividend of Rs 25 per share. Since shares mus...
- India’s growth faces crude and monsoon test as FY27 GDP seen moderating to 6.5%India's economic growth is projected to slow to about 6.5 per cent in fiscal year 2027. Higher costs, global tensions and a potentially wea...
- Earnings slowdown in FY27? JM Financial lists 5 sectors which must do the heavy liftingNifty 50 earnings growth fell short of expectations in FY25 and FY26. While Q4 FY26 results led to an upward revision for FY27E Nifty 50 EP...
- UBS downgrades BHEL shares to Neutral from Buy. Check target, key reasonsUBS has downgraded BHEL to "Neutral" from "Buy", citing a more balanced risk-reward outlook after the stock's strong run, though it raised ...
- Alkem Labs shares in focus as Goldman, Morgan Stanley, others purchase stake in Rs 930-crore block dealShares of Alkem Laboratories will be in focus after block deals worth around Rs 930 crore saw 17.88 lakh shares traded at Rs 5,200 apiece o...
- Skyroot Aerospace forecasts Rs 977 crore in revenues by FY27, ahead of Vikram-1 launchIndian space startup Skyroot Aerospace projects significant revenue growth, aiming for over Rs 13,000 crore by FY32, driven by launch servi...
- Wockhardt shares pause massive 36% rally in 5 sessions; slip 7%. What’s behind the selloff?Wockhardt shares dropped after a recent surge, as investors took profits. This followed the US FDA approval of ZAYNICH, an antibiotic for u...
- India meets FY26 fiscal deficit goal at 4.4% of GDP despite revenue and global pressuresIn a commendable feat, the Indian government has hit its FY26 fiscal deficit goal of 4.4% of GDP, largely due to prudent expenditure manage...
- JM Financial shares tank 8% as Q4 net profit declines 31% to Rs 162 croreJM Financial's shares plunged 8% following a significant drop in fourth-quarter net revenue and profit. While full-year profit after tax sa...
- Listed digital payment majors finally turn a corner in FY26Growth in the core payments business, expansion across credit products and wider adoption of revenue-generating payment instruments like cr...
- Pine Labs shares rise over 4% after Q4 results. Why Morgan Stanley forecasts 67% upsidePine Labs shares surged after the company reported a significant turnaround, posting a Rs 59 crore net profit in Q4FY26 against a loss last...
- Data spills at home; Green card limbo deepensHappy Tuesday! Recent data-collection experiments by on-demand platforms have drawn attention to Indian physical AI startups. This and more...
- Buy, Sell or Hold: Morgan Stanley maintains Equal-Weight on Pine Labs; retains buy on ONGCMorgan Stanley maintains a constructive outlook on select Indian largecap stocks in defence, energy, and fintech, citing strong growth pros...
- H-1B chill sets in; Flipkart doubles down on ShopsyUS demand for H-1B visas has slumped to a seven-year low amid steeper costs and Trump-era policy shifts. This and more in today’s ETtech To...
- Pine Labs Q4FY26: revenue up 17% to Rs 700 crore, net profit at Rs 59 crorePine Labs was listed in November 2025. Sharing details about its IPO proceeds, Pine Labs said that the company had raised Rs 2,080 crore in...
- Stocks in news: Premier Energies, Suzlon Energy, Paytm, Hindalco, ONGCIndian markets saw a strong rebound on Monday. The Nifty index surpassed 24,000 and is expected to move higher. Premier Energies saw a larg...
- Pine Labs Q4 Results: Co turns to black, logs Rs 59 crore profit on 17% revenue jumpPine Labs Q4 Results: Payments solutions provider Pine Labs turned profitable in the March-ended quarter, posting a consolidated net profit...
- Max Healthcare Q4 results: Cons PAT grows 7% YoY to Rs 342 crore, revenue rises 12%Max Healthcare Q4FY26 consolidated PAT grew 7% YoY, and revenue increased 12%. Network EBITDA rose 8%. Max Lab and Max@Home saw strong doub...
Load More
